Cypress Pharmaceutical rolls out new generic drug

by

Published: May 2,2011

Tags: drugs, manufacturing, medicine

MADISON — Cypress Pharmaceutical Inc. has commercially launched Epinastine HCl Ophthalmic Solution, 0.05%, which is AT-rated to Allergan’s ELESTAT (epinastine HCl ophthalmic solution) 0.05%.

As the first company to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for this product, Cypress has been awarded a 180-day period of marketing exclusivity.

Cypress, founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading national pharmaceutical wholesalers, chain drug stores, distributors and other retail merchandisers.

Source: Cypress Pharmaceutical Inc.

[RSS Feed] [del.icio.us]



To sign up for Mississippi Business Daily Updates, click here.

POST A COMMENT

 

Twang & Tourism: The Country Music Trail

Our annual "Come See Us" magazine offers ideas for spots in Mississippi ranging from golf to culture to history to food. Click the photo for ideas, stories and access to the digital edition of this year's magazine.

FOLLOW THE MBJ ON TWITTER

Top Posts & Pages

%d bloggers like this: